23 May 2013
Keywords: ph, iii, data, wyeth, relistor, injection, drug
Article | 09 June 2008
US drug major Wyeth Pharmaceuticals has published results for the final Phase III trial of its recently-approved Relistor (methylnaltrexone
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 June 2008
22 May 2013
© 2013 thepharmaletter.com